Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
In recent years, dual agonists of the incretin system have been tested in pre-clinical and early-phase clinical trials, with the glucose-dependent insulinotropic polypeptide and GLP-1 co-agonist, tirzepatide, recently approved for clinical use
Downstream processing Purification This unit operation removes impurities from the crude peptide following the cleavage step
GLP-1 medications work in a variety of ways to make healthy weight loss more achievable
Timing your injections can reduce these effects: Taking injections with or after meals may reduce nausea
AOM, anti-obesity medication
Our providers will help determine which option best fits your goals, health history, and lifestyle
US$ 22.33
US$ 27.87
US$ 22.64
US$ 26.10
